Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Teychenne

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Gastroenterology|March 1, 1979
Hepatocellular injury with distinctive mitochondrial changes induced by lergotrile mesylate: a dopaminergic ergot derivativeP F Teychenne, E A Jones, K G Ishak, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1979
Sodium valproate in the treatment of cerebellar disordersA N Neophytides, P F Teychenne, R F Pfeiffer, et al.
British Journal of Clinical Pharmacology|January 1, 1980
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrileP F Teychenne, A J Rosin, C N Plotkin, et al.
Annals of Neurology|April 1, 1978
Comparison between lergotrile and bromocriptine in parkinsonismP F Teychenne, R F Pfeiffer, S M Bern, et al.
Advances in Neurology|January 1, 1975
Dopaminergic agonists in ParkinsonismL E Claveria, P F Teychenne, D B Calne, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1976
Nomifensine in parkinsonismP F Teychenne, D M Park, L J Findley, et al.
The Medical Journal of Australia|November 4, 1978
Ergot derivatives for ParkinsonismD B Calne, A C Williams, J G Nutt, et al.
Lancet (London, England)|December 7, 1974
Treatment of parkinsonism with bromocriptineD B Calne, P F Teychenne, P N Leigh, et al.
Transactions of the American Neurological Association|January 1, 1974
Pimozide in tardive dyskinesiaD B Calne, L E Claveria, P F Teychenne, et al.
Clinical Pharmacology and Therapeutics|February 1, 1979
Bromocriptine inhibits norepinephrine releaseM G Ziegler, C R Lake, A C Williams, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Gastroenterology|March 1, 1979
Hepatocellular injury with distinctive mitochondrial changes induced by lergotrile mesylate: a dopaminergic ergot derivativeP F Teychenne, E A Jones, K G Ishak, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1979
Sodium valproate in the treatment of cerebellar disordersA N Neophytides, P F Teychenne, R F Pfeiffer, et al.
British Journal of Clinical Pharmacology|January 1, 1980
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrileP F Teychenne, A J Rosin, C N Plotkin, et al.
Annals of Neurology|April 1, 1978
Comparison between lergotrile and bromocriptine in parkinsonismP F Teychenne, R F Pfeiffer, S M Bern, et al.
Advances in Neurology|January 1, 1975
Dopaminergic agonists in ParkinsonismL E Claveria, P F Teychenne, D B Calne, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1976
Nomifensine in parkinsonismP F Teychenne, D M Park, L J Findley, et al.
The Medical Journal of Australia|November 4, 1978
Ergot derivatives for ParkinsonismD B Calne, A C Williams, J G Nutt, et al.
Lancet (London, England)|December 7, 1974
Treatment of parkinsonism with bromocriptineD B Calne, P F Teychenne, P N Leigh, et al.
Transactions of the American Neurological Association|January 1, 1974
Pimozide in tardive dyskinesiaD B Calne, L E Claveria, P F Teychenne, et al.
Clinical Pharmacology and Therapeutics|February 1, 1979
Bromocriptine inhibits norepinephrine releaseM G Ziegler, C R Lake, A C Williams, et al.
Pageof 3